AUG 20, 2019 02:37 PM PDT

Lab-on-a-chip Advances Search for Anti-Clotting Drugs

WRITTEN BY: Nouran Amin

A novel ‘lab-on-a-chip’ the size of a postage stamp could soon advance the developments of safer anti-clotting drugs for heart attack and stroke prevention. The effective use of current anti-clotting drugs are limited due to risk in complications which prompted the need for alternative therapeutics that can be safe to avoid the risk of a fatal bleed and strong enough for preventing blood clotting formation.

RMIT.EDU: The chip features a unique system of tiny channels and pumps for rapidly manipulating fluids.

Now, the new biocompatible lab-on-a-chip, which is detailed procedurally in the journal Analytical Chemistry, will help accelerate the search for new anti-clotting drugs. The development was designed to work with the complexity and sensitivity of the biology of blood.

"Blood is extremely sensitive to artificial surfaces and clots very easily, so blood-handling technologies must be equally sensitive," says lead investigator Dr. Warwick Nesbitt, who worked with various collaborators to pioneer the device. "We've combined a deep understanding of the biology of blood with precision microfabrication engineering and design, to deliver a device that can work with whole blood and produce reliable results.

The device can effectively function as a medical pathology laboratory onto a small chip, and uses quick automated processes that can be achieved in a few minutes which would instead take days in a full-sized lab. It features a system of micropumps and unique analysis tools to study the effectiveness of chemical compounds on blood clots.

Learn more about the early history of lab on a chip:

"We hope this powerful new tool will give researchers an edge in delivering better and safer anti-clotting treatments, to improve the health and wellbeing of millions around the world."

"It's a key step towards the development of quick and efficient microsystems for pre-clinical and clinical hematology screening and diagnostics,” says Dr. Crispin Szydzik on how the micro lab can mimic conditions inside blood vessels.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
HIV Therapeutics Places Risk of Neural Tube Defects
In a study published in the New England Journal of Medicine, women taking an HIV therapeutic drug containing dolutegravir have a higher risk of giving birt...
OCT 23, 2019
Cell & Molecular Biology
OCT 23, 2019
Relieving a Mechanism That Could Underlie as Many as 20 Rare Disorders
Toxic proteinopathies are a group of inherited diseases that are caused when improperly folded proteins accumulate in the cell....
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Re-Evaluating a Popular Heart Failure Drug
A recent study found that the popular heart drug--sacubitril/valsartan—holds positive effects on the structure and function of the failing heart. Spe...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
How Does Ketamine Treat Depression?
In recent years, ketamine has received growing interest for its neuroprotective effects. Known to alleviate symptoms of depression in just hours whereas co...
OCT 23, 2019
Drug Discovery & Development
OCT 23, 2019
Aspirin May Reduce Effects of Air Pollution on Lungs
New research findings, published in the American Journal of Respiratory and Critical Care Medicine, are the first to suggest that the nonsteroidal anti-inf...
OCT 23, 2019
Technology
OCT 23, 2019
New Encapsulation Technology
Research at the University of Waterloo has concluded new encapsulation technology that can offer an inexpensive, and effective method for coating liquid me...
Loading Comments...